236 related articles for article (PubMed ID: 36830696)
1. EVI2B Is a Prognostic Biomarker and Is Correlated with Monocyte and Macrophage Infiltration in Osteosarcoma Based on an Integrative Analysis.
Dai Z; Liu Z; Yang R; Cao W; Ji T
Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830696
[TBL] [Abstract][Full Text] [Related]
2. Analysis of scRNA-seq and bulk RNA-seq demonstrates the effects of EVI2B or CD361 on CD8
Xie T; Feng W; He M; Zhan X; Liao S; He J; Qin Z; Li F; Xu J; Liu Y; Wei Q
Exp Biol Med (Maywood); 2023 Jan; 248(2):130-145. PubMed ID: 36511103
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics analysis of the key genes in osteosarcoma metastasis and immune invasion.
Liang J; Chen J; Hua S; Qin Z; Lu J; Lan C
Transl Pediatr; 2022 Oct; 11(10):1656-1670. PubMed ID: 36345453
[TBL] [Abstract][Full Text] [Related]
4. Identification of prognostic biomarkers associated with metastasis and immune infiltration in osteosarcoma.
Yang B; Su Z; Chen G; Zeng Z; Tan J; Wu G; Zhu S; Lin L
Oncol Lett; 2021 Mar; 21(3):180. PubMed ID: 33574919
[TBL] [Abstract][Full Text] [Related]
5. Development of an immune-related prognostic index associated with osteosarcoma.
Yin CD; Hou YL; Liu XR; He YS; Wang XP; Li CJ; Tan XH; Liu J
Bioengineered; 2021 Dec; 12(1):172-182. PubMed ID: 33371790
[TBL] [Abstract][Full Text] [Related]
6.
Yonekura S; Ueda K
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439264
[TBL] [Abstract][Full Text] [Related]
7. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
8. Integrative analyses of ferroptosis and immune related biomarkers and the osteosarcoma associated mechanisms.
Li G; Lei J; Xu D; Yu W; Bai J; Wu G
Sci Rep; 2023 Apr; 13(1):5770. PubMed ID: 37031292
[TBL] [Abstract][Full Text] [Related]
9. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
10. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract][Full Text] [Related]
11. A novel stratification framework based on anoikis-related genes for predicting the prognosis in patients with osteosarcoma.
Zhang X; Wen Z; Wang Q; Ren L; Zhao S
Front Immunol; 2023; 14():1199869. PubMed ID: 37575253
[TBL] [Abstract][Full Text] [Related]
12. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma cancer.
Liu R; Hu Y; Liu T; Wang Y
BMC Cancer; 2021 Dec; 21(1):1345. PubMed ID: 34922489
[TBL] [Abstract][Full Text] [Related]
13. Construction and Validation of a Macrophage-Associated Risk Model for Predicting the Prognosis of Osteosarcoma.
Xiao KW; Liu ZB; Zeng ZH; Yan FF; Xiao LF; Li JL; Cai L
J Oncol; 2021; 2021():9967954. PubMed ID: 34188683
[TBL] [Abstract][Full Text] [Related]
14. N6-Methyladenosine-Related LncRNAs Are Potential Remodeling Indicators in the Tumor Microenvironment and Prognostic Markers in Osteosarcoma.
Wu Z; Zhang X; Chen D; Li Z; Wu X; Wang J; Deng Y
Front Immunol; 2021; 12():806189. PubMed ID: 35095893
[TBL] [Abstract][Full Text] [Related]
15. Single-Cell RNA Sequencing Pro-angiogenic Macrophage Profiles Reveal Novel Prognostic Biomarkers and Therapeutic Targets for Osteosarcoma.
Yi C; Li Z; Zhao Q; Gong D; Zhao S; Chen Z; Cheng C; Bian E; Tian D
Biochem Genet; 2024 Apr; 62(2):1325-1346. PubMed ID: 37603193
[TBL] [Abstract][Full Text] [Related]
16. Infiltration of LPAR5
He Y; Zhou H; Huang X; Qu Y; Wang Y; Pei W; Zhang R; Chen S; You H
Front Immunol; 2022; 13():909932. PubMed ID: 36591220
[TBL] [Abstract][Full Text] [Related]
17. Identification and verification of a BMPs-related gene signature for osteosarcoma prognosis prediction.
Xie L; Zeng J; He M
BMC Cancer; 2023 Feb; 23(1):181. PubMed ID: 36814224
[TBL] [Abstract][Full Text] [Related]
18. Development of novel gene signatures for the risk stratification of prognosis and diagnostic prediction of osteosarcoma patients using bioinformatics analysis.
Li G; Huang B; Wu H; Zhang H
Transl Cancer Res; 2022 Jul; 11(7):2374-2387. PubMed ID: 35966307
[TBL] [Abstract][Full Text] [Related]
19. PILRA is associated with immune cells infiltration in atrial fibrillation based on bioinformatics and experiment validation.
Shi W; Li X; Su Y; Liu D; Wu L; Li S; He W; Zhong G; Jiang Z
Front Cardiovasc Med; 2023; 10():1082015. PubMed ID: 37396579
[TBL] [Abstract][Full Text] [Related]
20. Low GNG12 Expression Predicts Adverse Outcomes: A Potential Therapeutic Target for Osteosarcoma.
Yuan J; Yuan Z; Ye A; Wu T; Jia J; Guo J; Zhang J; Li T; Cheng X
Front Immunol; 2021; 12():758845. PubMed ID: 34691083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
